Caspase-activation and induction of inducible nitric oxide-synthase during TNFα-triggered apoptosis

Anticancer Research

Volumn 19, Issue 3 A, 1999, Pages 1715-1720

  Binder, Claudia ^a   Schulz, Matthias ^a   Hiddemann, Wolfgang ^b   Oellerich, Michael ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Apoptosis; Caspases; iNOS; TNF

Indexed keywords

CASPASE; CASPASE INHIBITOR; CYCLOHEXIMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RADICAL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTIGENS, CD; APOPTOSIS; BREAST NEOPLASMS; CASPASES; CYCLOHEXIMIDE; CYSTEINE PROTEINASE INHIBITORS; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITORS; FEMALE; HUMANS; NEOPLASM PROTEINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PENICILLAMINE; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032781312     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hsu H, Xiong J and Goeddel D: The TNF receptor 1-associated protein TRADD signals cell death and NF-(B activation. Cell 81: 495-504, 1995.
2. Boldin M, Goncharov T, Goltsev Y and Wallach D: Involvement of MACH, a novel MORT/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803-815, 1996.
3. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326: 1-16, 1997.
4. Hsu H, Shu H-B, Pan M-G and Goeddel D: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308, 1996.
5. Thornberry NA and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998.
6. Cheng E, Kirsch DG, Clem RJ, Ravi R, Kastan MB, Bedi A, Ueno K, and Hardwick JM: Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278: 1966-1968, 1997.
7. L through caspase interaction. Proc Natl Acad Sci USA 95: 554-559, 1998.
8. Nicholson DW and Thornberry NA: Caspases: killer proteases. TIBS 22: 299-306, 1997.
9. Liu X, Zou H, Slaughter C and Wang X: DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 88: 175-184, 1998.
10. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064, 1992.
11. Tartaglia L, Ayres TM, Wong G and Goeddel D: A novel domain within the 55 kD TNF receptor signals cell death. Cell 74: 845-853, 1993.
12. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Verganci WA and Ziehe M: Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90: 587-596, 1998.
13. Klotz T, Bloch W, Volberg C, Engelmann U and Addicks K: Selective expression of inducible nitric oxide synthase in human prostate carcinoma. Cancer 82: 1897-1903, 1998.
14. Thomsen LL, Miles DW, Happerfiel L, Bobrow LG, Knowles RG and Moncada S: Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44, 1995.
15. Thomsen LL, Scott JM, Topley P, Knowles RG, Keerie A-J and Frend AJ: Selective inhibition of iNOS inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res 57: 3300-3304; 1997.
16. Ambs S, Merriam WG, Ogunfusika MO, Benett WP, Ishibe N, Hussain SP, Tzeng EE, Geller DA, Billiar TR and Harris CC: p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nature Med 4: 1371-1376; 1998.
17. Heneka MT, Löschmann PA, Gleichmann M, Weller M, Schulz JB, Wüllner U and Klockgether T: Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC 12 cells after stimulation with TNFα/lipopolysacharide. J Neurochem 71: 88-94, 1998.
18. Xie K, Huang S, Dong Z and Fidler J: Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric oxide. Int J Oncol 3. 1043-1048, 1993.
19. Leist M, Gantner F, Jilg S and Wendel A: Activation of the 55 kD TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis and nitrite release. J Immunol 154: 1307-1316, 1995.
20. Southern C and Matthews N: Nitric oxide is produced during TNF killing of U937A cells but does not contribute to the cytotoxic process. Biochim Biophys Acta 1177: 179-182, 1993.
21. Tzeng E, Billiar TR, Williams DL, Li J, Lizonova A, Kovesdi I and Kim Y-M: Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis. Surgery 124: 278-283, 1998.
22. Mannick JB, Asano K, Izumi K, Kieff E and Stamler JS: Nitric oxide produced by human B lymphocytes inhibits apoptosis and Ebstein-Barr virus reactivation. Cell 79: 1137-1146, 1994.
23. Chun S, Eisenhauer K, Kubo M and Hsueh A: Interleukin-1ß suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology 136: 3120-3127, 1995.
24. Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B, Sigaux F and KoIb JP: B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying antiapoptotic activity. Blood 92: 1031-1043, 1998.
25. Dimmeler S, Haendeler J, Nehls M and Zeiher A: Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP-32-like proteases. J Exp Med 185: 601-607, 1997.
26. Haendeler J, Weiland U, Zeiher AM and Dimmeler S: Effect of redox-related congeners of NO on apoptosis .and caspase-3 activity. Nitric Oxide 1: 282-293, 1997.
27. Filep J, Lapierre C, Lachance S and Chan J: Nitric oxide cooperates with hydrogen peroxide in inducing DNA fragmentation and cell lysis in murine lymphoma cells. Biochem J 321: 897-901, 1997.
28. Wink D, Cook J, Kim S, Vodovotz Y, Pacelli R, Krishna M, Russo A, Mitchell J, Jourdheuil D, Miles A and Grisham M: Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. J Biol Chem 272: 11147-11151, 1997.
29. Brüne B, Gωtz C, Messmer U, Sandau K, Hirvonen M-R and Lapetina E: Superoxide formation and macrophage resistance to nitric-oxide mediated apoptosis. J Biol Chem 272: 7253-7258, 1997.
30. Stamler JS: Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78: 931-936, 1994.
31. Brüne B, Mohr S and Messmer U: Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide signaling pathways. Rev Physiol Biochem Pharmacol 127: 4-26, 1995.
32. Dubrez L, Savoy I, Hamman A and Solary E: Pivotal rile of a DEVD-sensitive step in etoposide-induced and Fas-mediated apoptotic pathways. EMBO J 15: 5504-5512, 1996.
33. Binder C, Binder L, Kroemker M, Schulz M and Hiddemann W: Influence of cycloheximide-mediated downregulation of glucose transport on TNFα-induced apoptosis. Exp Cell Research 236: 223-230, 1997.
34. Chomczynski P and Sacchi N : Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Clin Biochem 162; 156-159, 1987.
35. Binder C, Schulz M, Hiddemann W and Oellerich M: Induction of inducible nitric oxide-synthase is an essential part of TNFα-induced apoptosis in MCF-7 and other epithelial tumor cells. Manuscript submitted.
36. Crow JP, Ye YZ, Royall J, Kooy N and Beckman JS: Evidence of peroxynitrite formation in vivo: detection of nitrated proteins with an anti-nitrotyrosine antibody. In: The biology of nitric oxide 4 (Moncada S, Feelisch M, Busse R and Higgs EA eds). London, Portland Press, 1994, pp 20-24.
37. Wissing D, Mouritzen H, Egeblad M, Poirier G and Jäättelä M: Involvement of caspase-dependent activation of cytosolic phospholipase A2 in TNF-induced apoptosis. Proc Natl Acad Sci USA 94: 5073-5077, 1997.
38. Slowik MR, Min W, Ardito T, Karsan A, Kashgarian M and Pober JS: Evidence that tumor necrosis factor triggers apoptosis in human endothelial cells by interleukin-1-converting enzyme-like protease-dependent and -independent pathways. Lab Invest 77: 257-267, 1997.
39. Haviv R and Stein R: The intracellular domain of p55 TNF receptor induces apoptosis which requires different caspases in naive and neuronal PC 12 cells. J Neurosci Res 52: 380-389, 1998.
40. Jänicke RU, Sprengart ML, MR Wati and Porter AG: Caspase-3 is required for DNA fragmentation and morphologic changes associated with apoptosis. J Biol Chem 273: 9357-9360, 1998.
41. Chlichlia K, Peter ME, Rocha M, Scaffidi C, Bucur M, Krammer PH, Schirrmacher V and Umansky V: Caspase activation is required for nitric oxide-mediated CD 95(APO-1/Fas)-dependent and -independent apoptosis in human neoplastic lymphoid cells. Blood 91: 4311-4320, 1998.
42. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa L, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM and Mak TW: Differential reqirement for caspase 9 in apoptotic pathways in vivo. Cell 94: 339-352, 1998.
43. Kuida K, Haydar TF, Kuan C-Y, Gu Y, Taya C, Karasuyama H, Su M, Rakic P and Flavell RA: Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9, Cell 94: 325-337, 19998.
44. Jäättelä M, Wissing D, Kokholm K, Kallunki T and Egeblad M: Hsp70 exerts its antiapoptotic effect further downstream of caspase 3-like proteases. EMBO J 17: 6124-6134, 1998.
45. Brockhaus F and Brüne B: U 937 apoptotic cell death by nitric oxide: Bcl-2 downregulation and caspase activation. Exp Cell Res 238: 33-41, 1998.
46. Wright SC, Schellenberger U, Wang H, Kinder DH, Talhouk JW and Larrick JW: Activation of CPP32-like proteases is not sufficient to trigger apoptosis: inhibition of apoptosis by agents that suppress activation of AP24, but not CPP32-like activity. J Exp Med 186: 1107-1117, 1997.